Bold Therapeutics Heads to Lisbon for BIO Europe Spring 2026 to Advance Cancer Drug Partnerships
Bold Therapeutics is set to participate in BIO Europe Spring 2026 in Lisbon, positioning itself at one of the industry’s key gatherings to strengthen partnerships and showcase progress in oncology research. The Vancouver based biopharmaceutical company will attend the event from March 23 to 25, where it plans to engage with global collaborators, investors and […]